Literature DB >> 27016314

Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder.

Roberto De Marzi1, Klaus Seppi1,2, Birgit Högl1, Christoph Müller1, Christoph Scherfler1,2, Ambra Stefani1, Alex Iranzo3, Eduardo Tolosa3, Joan Santamarìa3, Elke Gizewski2,4, Michael Schocke2,4, Elisabeth Skalla2,4, Christian Kremser2,4, Werner Poewe1,2.   

Abstract

We assessed loss of dorsolateral nigral hyperintensity (DNH) on high-field susceptibility-weighted imaging (SWI), a novel magnetic resonance imaging marker for Parkinson's disease (PD), in 15 subjects with idiopathic rapid eye movement sleep behavior disorder (iRBD) and compared findings to 42 healthy controls (HCs) and 104 PD patients. We found loss of DNH in at least two thirds of iRBD subjects, which approaches the rate observed in PD and is in contrast to findings in HCs. We propose that absence of DNH on high-field SWI could identify prodromal degenerative parkinsonism in iRBD. Ann Neurol 2016;79:1026-1030.
© 2016 American Neurological Association.

Entities:  

Mesh:

Year:  2016        PMID: 27016314     DOI: 10.1002/ana.24646

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  35 in total

1.  Clinical utility of visualisation of nigrosome-1 in patients with Parkinson's disease.

Authors:  Albert Stezin; Rajini M Naduthota; Ragasudha Botta; Shriram Varadharajan; Abhishek Lenka; Jitender Saini; Ravi Yadav; Pramod Kumar Pal
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

Review 2.  Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.

Authors:  Daniel A Barone; Claire Henchcliffe
Journal:  Clin Neurophysiol       Date:  2018-05-29       Impact factor: 3.708

Review 3.  Biomarkers of Parkinson's disease: 20 years later.

Authors:  Rezzak Yilmaz; Franziska Hopfner; Thilo van Eimeren; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2019-04-04       Impact factor: 3.575

4.  What the "man in the moon" can tell us about the future of our brains.

Authors:  Birgit Högl
Journal:  Ann Transl Med       Date:  2017-09

5.  Present and Future of Ultra-High Field MRI in Neurodegenerative Disorders.

Authors:  Graziella Donatelli; Roberto Ceravolo; Daniela Frosini; Michela Tosetti; Ubaldo Bonuccelli; Mirco Cosottini
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-20       Impact factor: 5.081

Review 6.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

Review 7.  Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.

Authors:  Xiaojun Guan; Xiaojun Xu; Minming Zhang
Journal:  Neurosci Bull       Date:  2017-05-17       Impact factor: 5.203

Review 8.  New Imaging Markers for Movement Disorders.

Authors:  Christine Ghadery; Antonio P Strafella
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-03       Impact factor: 5.081

Review 9.  REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions.

Authors:  Erik K St Louis; Bradley F Boeve
Journal:  Mayo Clin Proc       Date:  2017-11-01       Impact factor: 7.616

Review 10.  Innovative Approaches for Slowing Disease Progression in Parkinson's Disease: Takeaways from the 14th Annual International Society for Central Nervous System Clinical Trials and Methodology Scientific Meeting.

Authors:  Monica Javidnia; Mark Frasier; Ira Shoulson; Ibrahim Turkoz; Kumar Budur
Journal:  Innov Clin Neurosci       Date:  2020-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.